[An earlier version of this post misinterpreted Pfizer CEO Albert Bourla's English. It seemed like he was sowing doubt about the safety of his own COVID shots. Instead, he was alluding to a "safety profile" issue regarding his competitor's current shingles vaccination (Shingrix is made by Pfizer competitor GSK and it has 90% market share), which he claimed can be solved with mRNA.]The Pfizer chief appeared on Squawk Box this morning after the company announced several agreements in the fields of gene editing, with the hopes to use these technologies to bolster the mRNA platform for their COVID shots.
But that was only half the story.
once claimed were 100% effective at preventing the disease — now only "offers very limited protection, if any."
He said this in the context of pushing for a new round of shots for the Omicron variant.
Truly, unbelievable stuff. In a series of interviews, Bourla attempted to change the entire COVID narrative, while simultaneously sowing incredible doubt about the efficacy of his current product line up.
Here's the link to the full CNBC interview.